Precision Medicine Market Size, Trends and Insights By Technology (Big data analytics, Bioinformatics, Gene sequencing, Companion diagnostics, Others), By Application (Immunology, Respiratory, Oncology, Central nervous system, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032


Report Code: CMI17978

Published Date: August 2022

Pages: 220+

Category: Pharmaceuticals

Report Snapshot

CAGR: 11.5%
78.58B
2021
89.16B
2022
189.64B
2030

Source: CMI

Study Period: 2022-2030
Fastest Growing Market: Asia-Pacific
Largest Market: Europe

Major Players

  • Novartis
  • Qiagen
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Others

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

The precision medicine market presented an earning of USD 78.58 billion by the year 2021 to 89.16 billion in 2022 and is foreseen to touch USD 189.64 billion by the end of 2030 with a compound annual growth rate of 11.5%.

Precision medicine is mostly used in the healthcare industry to provide patients with sophisticated diagnostic tools to identify a specific disease before its problems manifest themselves. As a result, the healthcare system may better prepare for dealing with various ailments and achieve better results by curing the patients more quickly.

To rule out the possibility of various chronic diseases, the genetic component of the individual is taken into account and examined appropriately. The need for precision medicine has skyrocketed in the current industry due to the rising prevalence of serious diseases like cancer. The high cost of these medical facilities makes it difficult for the average person to choose them, which restrains the market’s growth throughout the projection period.

The growth of the precision medicine market has been significantly constrained by the people’s declining disposable income. People all over the world’s poor lifestyle choices have also been shown to be a significant contributor to a number of ailments. The most effective alternative for treating these many ailments turns out to be precision medicine.

COVID-19 Analysis:

The COVID pandemic’s existence has a significant impact on the market for precision medicine. Due to the pandemic, regular patient follow-ups and continued long-term therapies were hampered because hospitals chose elective operations and treatments to reduce the likelihood of cross-infection. Nonetheless, the difficulties that were caused among the susceptible group might be effectively addressed with the use of precision medicine.

The market for precision medicine has grown significantly as a result of rising public knowledge of recent innovations in the healthcare industry. In recent years, the lucrative reimbursement facilities offered by the government with the assistance of health insurance providers have proven to be a significant growth factor for the precision medicine market. It is anticipated that this trend will continue throughout the projection period as well.

Growth Elements:

Precision medicine is more in demand on the market due to the rising desire for current technology in the healthcare industry. Precision medicine is more in demand now than ever before due to the rapidly rising incidence of cancer among people. Modern medications cause less side effects than older ones, which has proven to be a key driver of market expansion for precision medicine.

The intensive research and development efforts made by the major market players to bring new, modern medications with improved efficacy on human health to market have proven to be a fantastic opportunity for the developing market. These causes will show to be the driving forces of progress.

Segmental insights

Segmentation of the precision medicine market on the basis of technology

Due to the substantial research and development activities carried out by the major market participants in order to bring cutting-edge medications to society, the drug discovery segment displayed the highest growth in terms of technology. Significant technological advancements are being made in order to raise the standard of medicines and release new ones onto the market that are more effective against the rising number of chronic diseases worldwide.

The goal is to extend people’s lives as much as possible, and by doing so, the market will experience significant growth over the course of the projection period. A significant driver in the market’s expansion has been the employment of contemporary medications to treat a multitude of chronic ailments that have lately appeared in society as a result of people’s poor living patterns. Pharmacogenomics, which helps the maker differentiate between pharmacodynamics and pharmacokinetics using the genetic information of a specific individual, is used to forecast the effectiveness of a new drug.

The fierce competition among the major market participants to release innovative medicines for the treatment of diseases like cancer has significantly accelerated the market’s growth phase. The following-largest technology segment is bioinformatics, which is anticipated to experience rapid expansion due to the expanding market throughout the forecast period. The following area that falls under this sector is big data analytics, which has experienced significant expansion over time as a result of rising demand. The following sub-segments in this category, companion diagnostics and gene sequencing contribute to the market’s sustained expansion.

Global Precision Medicine Market 2023 – 2032 (By Product)

www.custommarketinsight.com

Segmentation of the precision medicine market on the basis of application

Based on application, the rapid modernization of the systems has resulted in an increase in cancer prevalence among people, which has proven to be a significant growth factor for this segment within this category. A significant element driving up demand for cutting-edge medications is the numerous difficulties linked to cancer condition. The enormous geriatric population has contributed to an increase in cancer prevalence in society.

A significant factor that has increased the number of cancer cases worldwide is the poor lifestyle choices that people make as a result of growing urbanisation. Precision medicine is used to investigate the patient’s hereditary factors and identify the root causes of the disease. This technique has made it easier to create individualised drugs to treat specific individuals, which are more effective in controlling the spread of disease in a shorter amount of time.

The standard medical practices that are used in the healthcare industry do not assess the patient’s condition based on genetics. Precision medicine has become increasingly popular in the healthcare industry as a result of the rising desire for quicker treatment alternatives caused by global modernization. Due to its high prevalence among individuals, the number of cancer cases is driving it to rise in the next years. This is assisting the market in the cancer sector of the precision medicine market to record significant income over the course of time. Due to the increased stress and workload that individuals are under, diseases that affect the central nervous system have also experienced enormous growth in recent years. The demand for precision medicine in the modern healthcare industry has increased due to the frequency of central nervous system illnesses.

The demand for precision medicine for respiratory diseases has increased due to the rising prevalence of respiratory ailments among people as a result of the increasing environmental pollution on a global scale. Due to the people’s weakened respiratory systems after contracting the disease, the pandemic epidemic had a substantial effect on this market. Also, it had a favorable effect on people’s health by making them aware of the importance of health

Report Scope

Feature of the Report Details
Market Size in 2021 USD 78.58 billion
Projected Market Size in 2030 USD 189.64 billion
CAGR Growth Rate 11.5% CAGR (2022-2030)
Base Year 2022
Forecast Period 2023-2032
Prominent Players Novartis, Qiagen, Biocrates Life Sciences, Tepnel Pharma Services, Quest Diagnostics, Menarini Silicon Biosystems, Pfizer, Intomics, NanoString Technologies, Eagle Genomics, Roche, Teva Pharmaceutical, and Others
Key Segment By Technology, Application, and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors, and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfill your requirements for research.

Regional Perspectives:

Geographically, the market has been driven by North America, which has experienced the quickest development due to an increase in the frequency of chronic diseases among people. Modern technology’s presence in this field has increased the demand for precision medicine by educating people about the cutting-edge medical resources at their disposal.

The market for precision medicine has been boosted by the various initiatives that the government and private organizations have undertaken to raise awareness about the cutting-edge healthcare system and the treatment options that are available. This trend is expected to continue throughout the forecast period.

The government has supported the different profitable offers made by the insurance business and the healthcare sector in the form of reimbursement facilities, which has helped to enlarge the market and boost income returns over time.

Due to the numerous chronic diseases that are becoming more prevalent in society and the rising average life expectancy of the population, there is a greater demand for precision medicine. With more money in their pockets thanks to rising incomes, consumers can now choose to use cutting-edge medical services like precision medicine, which aids in the early detection and treatment of serious illnesses. Due to the rise in chronic illnesses among the population, Europe’s geographic region has also seen a modest increase in the need for precision medicine. The government’s provision of cutting-edge healthcare facilities has assisted the precision medicine market in recording significant growth and is anticipated to continue doing so over the course of the forecast period.

South American and Middle Eastern nations have also made substantial contributions to the rising need for cutting-edge healthcare systems to stop the spread of serious illnesses. As a result of the increasing status of the nations that are adopting contemporary amenities to give their citizens a better lifestyle, the Asia Pacific region has exhibited respectable growth in the market.

Global Precision Medicine Market 2023 – 2032 (By Billion)

www.custommarketinsight.com

Recent Developments

  • In order to manufacture the components for Kymriah gene therapy, Oxford Biomedica, and Novartis came to an agreement in 2017 covering the supply of critical ingredients. Within three years, it is anticipated that this agreement will provide Oxford Biomedica with a sizable revenue of approximately $100 million. On the other hand, Novartis planned to grow Kymriah into a company that generated $1 billion annually.

Global Precision Medicine Market 2023 – 2032 (By Route of Administration)

www.custommarketinsight.com

Segments covered in the report on the precision medicine market

By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others

On the basis of Geography

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Precision Medicine Market, (2022 – 2030) (USD Billion)
    • 2.2 Global Precision Medicine Market: snapshot
  • Chapter 3. Global Precision Medicine Market – Industry Analysis
    • 3.1 Precision Medicine Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing number of cases of cancer
      • 3.2.2 The demand for precision medicine
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Technology
      • 3.7.2 Market attractiveness analysis By Application
  • Chapter 4. Global Precision Medicine Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Precision Medicine Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Precision Medicine Market – Technology Analysis
    • 5.1 Global Precision Medicine Market overview: By Technology
      • 5.1.1 Global Precision Medicine Market share, By Technology, 2021 and 2030
    • 5.2 Big Data Analytics
      • 5.2.1 Global Precision Medicine Market by Big Data Analytics, 2022 – 2030 (USD Billion)
    • 5.3 Bioinformatics
      • 5.3.1 Global Precision Medicine Market by Bioinformatics, 2022 – 2030 (USD Billion)
    • 5.4 Gene Sequencing
      • 5.4.1 Global Precision Medicine Market by Gene Sequencing, 2022 – 2030 (USD Billion)
    • 5.5 Companion Diagnostics
      • 5.5.1 Global Precision Medicine Market by Companion Diagnostics, 2022 – 2030 (USD Billion)
    • 5.6 Others
      • 5.6.1 Global Precision Medicine Market by Others, 2022 – 2030 (USD Billion)
  • Chapter 6. Global Precision Medicine Market – Application Analysis
    • 6.1 Global Precision Medicine Market overview: By Application
      • 6.1.1 Global Precision Medicine Market share, By Application, 2021 and 2030
    • 6.2 Immunology
      • 6.2.1 Global Precision Medicine Market by Immunology, 2022 – 2030 (USD Billion)
    • 6.3 Respiratory
      • 6.3.1 Global Precision Medicine Market by Respiratory, 2022 – 2030 (USD Billion)
    • 6.4 Oncology
      • 6.4.1 Global Precision Medicine Market by Oncology, 2022 – 2030 (USD Billion)
    • 6.5 Central Nervous System
      • 6.5.1 Global Precision Medicine Market by Central Nervous System, 2022 – 2030 (USD Billion)
    • 6.6 Others
      • 6.6.1 Global Precision Medicine Market by Others, 2022 – 2030 (USD Billion)
  • Chapter 7. Precision Medicine Market – Regional Analysis
    • 7.1 Global Precision Medicine Market Regional Overview
    • 7.2 Global Precision Medicine Market Share, by Region, 2021 & 2030 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Precision Medicine Market, 2022 – 2030 (USD Billion)
        • 7.3.1.1 North America Precision Medicine Market, by Country, 2022 – 2030 (USD Billion)
    • 7.4 North America Precision Medicine Market, by Technology, 2022 – 2030
      • 7.4.1 North America Precision Medicine Market, by Technology, 2022 – 2030 (USD Billion)
    • 7.5 North America Precision Medicine Market, by Application, 2022 – 2030
      • 7.5.1 North America Precision Medicine Market, by Application, 2022 – 2030 (USD Billion)
    • 7.6. Europe
      • 7.6.1 Europe Precision Medicine Market, 2022 – 2030 (USD Billion)
        • 7.6.1.1 Europe Precision Medicine Market, by Country, 2022 – 2030 (USD Billion)
    • 7.7 Europe Precision Medicine Market, by Technology, 2022 – 2030
      • 7.7.1 Europe Precision Medicine Market, by Technology, 2022 – 2030 (USD Billion)
    • 7.8 Europe Precision Medicine Market, by Application, 2022 – 2030
      • 7.8.1 Europe Precision Medicine Market, by Application, 2022 – 2030 (USD Billion)
    • 7.9. Asia Pacific
      • 7.9.1 Asia Pacific Precision Medicine Market, 2022 – 2030 (USD Billion)
        • 7.9.1.1 Asia Pacific Precision Medicine Market, by Country, 2022 – 2030 (USD Billion)
    • 7.10 Asia Pacific Precision Medicine Market, by Technology, 2022 – 2030
      • 7.10.1 Asia Pacific Precision Medicine Market, by Technology, 2022 – 2030 (USD Billion)
    • 7.11 Asia Pacific Precision Medicine Market, by Application, 2022 – 2030
      • 7.11.1 Asia Pacific Precision Medicine Market, by Application, 2022 – 2030 (USD Billion)
    • 7.12. Latin America
      • 7.12.1 Latin America Precision Medicine Market, 2022 – 2030 (USD Billion)
        • 7.12.1.1 Latin America Precision Medicine Market, by Country, 2022 – 2030 (USD Billion)
    • 7.13 Latin America Precision Medicine Market, by Technology, 2022 – 2030
      • 7.13.1 Latin America Precision Medicine Market, by Technology, 2022 – 2030 (USD Billion)
    • 7.14 Latin America Precision Medicine Market, by Application, 2022 – 2030
      • 7.14.1 Latin America Precision Medicine Market, by Application, 2022 – 2030 (USD Billion)
    • 7.15. The Middle-East and Africa
      • 7.15.1 The Middle-East and Africa Precision Medicine Market, 2022 – 2030 (USD Billion)
        • 7.15.1.1 The Middle-East and Africa Precision Medicine Market, by Country, 2022 – 2030 (USD Billion)
    • 7.16 The Middle-East and Africa Precision Medicine Market, by Technology, 2022 – 2030
      • 7.16.1 The Middle-East and Africa Precision Medicine Market, by Technology, 2022 – 2030 (USD Billion)
    • 7.17 The Middle-East and Africa Precision Medicine Market, by Application, 2022 – 2030
      • 7.17.1 The Middle-East and Africa Precision Medicine Market, by Application, 2022 – 2030 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Novartis
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Qiagen
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Biocrates Life Sciences
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Tepnel Pharma Services
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Quest Diagnostics
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Menarini Silicon Biosystems
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Pfizer
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Intomics
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 NanoString Technologies
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Eagle Genomics
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Roche
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 Teva Pharmaceutical
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments

List Of Figures

Figures No 1 to 24

List Of Tables

Tables No 1 to 52

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2028
  • Market revenue estimates and forecasts up to 2028, by technology
  • Market revenue estimates and forecasts up to 2028, by application
  • Market revenue estimates and forecasts up to 2028, by type
  • Market revenue estimates and forecasts up to 2028, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Key Market Players

  • Novartis
  • Qiagen
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • Pfizer
  • Intomics
  • NanoString Technologies
  • Eagle Genomics
  • Roche
  • Teva Pharmaceutical
  • Others

FAQs

The “North America” region will lead the global Precision Medicine market during the forecast period 2022 to 2030.

A rapidly increasing number of cases of cancer among people has also boosted the demand for precision medicine.

The key players operating in the Precision Medicine market are Novartis, Qiagen, Biocrates Life Sciences, Tepnel Pharma Services, Quest Diagnostics, Menarini Silicon Biosystems, Pfizer, Intomics, NanoString Technologies, Eagle Genomics, Roche, Teva Pharmaceutical, and Others.

The global Precision Medicine market is expanding growth with a CAGR of approximately 11.5% during the forecast period (2022 to 2030).

The global Precision Medicine market size was valued at USD 66.1 billion in 2021 and it is projected to reach around USD 175.64 billion by 2030.

PURCHASE OPTIONS

$

3490


$

4490


$

5490


$

1950


powerbi pdf
$

6200

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • PDF, Excel, Power Point and Power BI.
  • Every Year Free Update ( Apr – Apr)
  • Personalized market brief by author
  • Can be accessible by unlimited users.
  • Free 50% or 90 hours of customization.
  • Up to 50 Company Profiles
  • Free post-sale service assistance with guarantee
  • 40% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account team.
  • Service guarantee available.

Want to customize this report?
100% FREE CUSTOMIZATION!